| BCNIE | Blood culture negative infective endocarditis |
| BMI | Body mass index |
| CABG | Coronary artery bypass grafting |
| CoNS | Coagulase-negative staphylococci |
| COPD | Chronic obstructive pulmonary disease |
| ECLS | Extracorporeal life support |
| EuroSCORE II | European System for Cardiac Operative Risk Evaluation II |
| HACEK | Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species |
| HIV | Human immunodeficiency virus |
| IABP | Intra-aortic balloon pump |
| ICU | Intensive care unit |
| IE | Infective endocarditis |
| LCOS | Low cardiac output syndrome |
| LVEF | Left ventricle ejection fraction |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| MSSA | Methicillin-susceptible Staphylococcus aureus |
| NVE | Native valve endocarditis |
| NYHA | New York Heart Association |
| PMV | Postoperative mechanical ventilation |
| PVE | Prosthetic valve endocarditis |
| SAVR–PVE | Prosthetic valve endocarditis following surgical aortic valve replacement |
| STS-PROM | Society of thoracic surgeons predicted risk of mortality |
| TAVR | Transcatheter aortic valve replacement |
| TIE | Prosthetic valve endocarditis following transcatheter aortic valve replacement |